Optiver Holding B.V. Biogen Inc. Transaction History

Optiver Holding B.V.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $222 - $267	1 New	1 $0
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $12,460 - $17,181	64 New	64 $17,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $16,979 - $22,143	-60 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $3.53 Million - $5.65 Million	-13,624 Reduced 99.56%	60 $21,000
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $3.32 Million - $3.89 Million	13,684 New	13,684 $3.83 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

Stay updated on Optiver Holding B.V. with notifications on news.